# Safety and Efficacy of Peginesatide for the Treatment of Anemia in Participants With Chronic Renal Failure Not on Dialysis

> **NCT00598442** · PHASE3 · COMPLETED · sponsor: **Affymax** · enrollment: 493 (actual)

## Conditions studied

- Chronic Renal Failure
- Chronic Kidney Disease
- Anemia

## Interventions

- **DRUG:** peginesatide
- **DRUG:** peginesatide
- **DRUG:** Darbepoetin alfa

## Key facts

- **NCT ID:** NCT00598442
- **Lead sponsor:** Affymax
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-11
- **Primary completion:** 2009-07
- **Final completion:** 2009-12
- **Target enrollment:** 493 (ACTUAL)
- **Last updated:** 2013-02-12

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00598442

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00598442, "Safety and Efficacy of Peginesatide for the Treatment of Anemia in Participants With Chronic Renal Failure Not on Dialysis". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT00598442. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*